Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02383927
Title Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Kura Oncology, Inc.

head and neck squamous cell carcinoma

squamous cell carcinoma

thyroid gland cancer



Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST